Novantrone and Copaxone drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Novantrone and Copaxone together. This review analyzes the effectiveness and drug interactions between Novantrone and Copaxone. It is created by eHealthMe based on reports of 163 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Novantrone and Copaxone, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Novantrone and Copaxone

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Novantrone

Novantrone has active ingredients of mitoxantrone hydrochloride. It is often used in multiple sclerosis. (latest outcomes from Novantrone 3,126 users)

Copaxone

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. (latest outcomes from Copaxone 27,332 users)

On Jan, 23, 2017

163 people who take Novantrone, Copaxone are studied.


Number of reports submitted per year:

Novantrone and Copaxone drug interactions.

Most common drug interactions over time *:

< 1 month:
  • cardiac disorder
  • hyperhidrosis
  • myalgia
  • paralysis
  • skin reaction
  • atrial fibrillation
  • atrial pressure increased
  • cardiac failure congestive
  • cardiomyopathy
  • chest pain
1 - 6 months:
  • hypovolaemic shock
  • myocardial infarction
  • renal insufficiency
  • respiratory failure
  • septic shock
  • stevens johnson syndrome
  • acute promyelocytic leukaemia
  • breast cancer female
  • cardiac failure
  • cellulitis gangrenous
6 - 12 months:
  • staphylococcal infection
  • headache
  • asthma
  • bladder disorder
  • upper respiratory tract infection
  • accident
  • oesophageal carcinoma
  • road traffic accident
  • metastases to liver
  • catheter related infection
1 - 2 years:
  • acute promyelocytic leukaemia
  • nausea
  • cerebrovascular accident
  • cholecystitis
  • deep vein thrombosis
  • haematuria
  • oesophageal carcinoma
  • acute myeloid leukaemia
  • cardiac failure
  • disseminated intravascular coagulation
2 - 5 years:
  • acute promyelocytic leukaemia
  • amenorrhoea
  • liposarcoma
  • metastases to liver
  • premature menopause
  • red blood cell count decreased
  • small intestine carcinoma metastatic
  • acute myeloid leukaemia
  • affect lability
  • anaemia
5 - 10 years:
  • cholecystitis
  • circulatory collapse
  • deep vein thrombosis
  • breast cancer
  • liposarcoma
  • acute promyelocytic leukaemia
  • apparent life threatening event
  • arthralgia
  • cerebrovascular accident
  • chest pain
10+ years:
  • alopecia
  • gastrooesophageal reflux disease
  • weight decreased
not specified:
  • multiple sclerosis relapse
  • nausea
  • acute myeloid leukaemia
  • staphylococcal infection
  • fatigue
  • myocardial infarction
  • pneumonia
  • gait disturbance
  • multiple sclerosis
  • syncope

Most common drug interactions by gender *:

female:
  • staphylococcal infection
  • headache
  • bladder disorder
  • asthma
  • multiple sclerosis relapse
  • upper respiratory tract infection
  • accident
  • nausea
  • acute myeloid leukaemia
  • cardiac failure
male:
  • acute promyelocytic leukaemia
  • oesophageal carcinoma
  • metastases to liver
  • myocardial infarction
  • cerebrovascular accident
  • metastases to bone
  • nausea
  • pneumonia
  • cholecystitis
  • convulsion

Most common drug interactions by age *:

20-29:
  • b precursor type acute leukaemia
  • back pain
  • bronchopulmonary aspergillosis
  • cerebrovascular accident
  • cough
  • cystitis
  • decubitus ulcer
  • disease progression
  • diverticulitis
  • haematoma
30-39:
  • staphylococcal infection
  • headache
  • asthma
  • bladder disorder
  • upper respiratory tract infection
  • accident
  • multiple sclerosis relapse
  • nausea
  • road traffic accident
  • amenorrhoea
40-49:
  • myocardial infarction
  • ejection fraction decreased
  • nausea
  • acute promyelocytic leukaemia
  • cerebrovascular accident
  • cholecystitis
  • deep vein thrombosis
  • convulsion
  • fatigue
  • haematemesis
50-59:
  • oesophageal carcinoma
  • metastases to liver
  • nausea
  • acute promyelocytic leukaemia
  • alopecia
  • haematuria
  • metastases to bone
  • multiple sclerosis
  • acute myeloid leukaemia
  • chest pain
60+:
  • cardiac failure
  • pneumonia
  • multiple sclerosis relapse
  • colon cancer
  • constipation
  • helicobacter infection
  • infection susceptibility increased
  • left ventricular dysfunction
  • malaise
  • pancreatic carcinoma

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Novantrone and Copaxone?

Interactions between Novantrone and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Copaxone and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Novantrone (mitoxantrone hydrochloride) is often used to treat multiple sclerosis. Copaxone (glatiramer acetate) is often used to treat multiple sclerosis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Can you answer these questions?

More questions for: Novantrone, Copaxone

You may be interested in these reviews

More reviews for: Novantrone, Copaxone